Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Future Med Chem ; 13(4): 363-378, 2021 02.
Article in English | MEDLINE | ID: covidwho-1389653

ABSTRACT

Background: The SARS-CoV-2 3CLpro is one of the primary targets for designing new and repurposing known drugs. Methodology: A virtual screening of molecules from the Natural Product Atlas was performed, followed by molecular dynamics simulations of the most potent inhibitor bound to two conformations of the protease and into two binding sites. Conclusion: Eight molecules with appropriate ADMET properties are suggested as potential inhibitors. The greatest benefit of this study is the demonstration that these ligands can bind in the catalytic site but also to the groove between domains II and III, where they interact with a series of residues which have an important role in the dimerization and the maturation process of the enzyme.


Subject(s)
Antiviral Agents/pharmacology , Biological Products/pharmacology , SARS-CoV-2/drug effects , Binding Sites , COVID-19/prevention & control , Computational Biology , Drug Design , Drug Repositioning , Humans , Ligands , Molecular Docking Simulation , Molecular Dynamics Simulation , Nucleosides/pharmacology , Peptide Hydrolases/chemistry , Protease Inhibitors/chemistry , Protein Binding , Protein Multimerization , Software , Viral Nonstructural Proteins/antagonists & inhibitors , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL